Submitted by CRB
CRB is proud to announce that the Amicus Therapeutics Research and Gene Therapy Center facility has won Engineering News-Record (ENR) MidAtlantic’s 2020 Best Projects (Award of Merit) in the Healthcare category.
Two panels of industry judges reviewed more than 80 projects located throughout the region, including Delaware, Maryland, Pennsylvania, Virginia, West Virginia, and the District of Columbia. Projects were scored on the ability of the project team to overcome challenges, contribution to the industry and community, project innovation, safety, and construction/design quality.
Amicus is a biopharmaceutical company that discovers and develops medicines for rare diseases. It’s global research and gene therapy center of excellence consolidates Amicus’ five research departments into a unified space on the top two floors of a 14-story tower. The research workplace is the convergence of technical laboratories, office, and amenity spaces. The design creates spaces that connect science, people and purpose.
Our team provided architectural, engineering, and lab design to realize our client’s vision: a standout research facility that would attract and retain top researchers, promote collaboration, and break down barriers between employees to rapidly advance these potentially life-saving therapies through the drug pipeline.
To read more about the ENR 2020 Best Projects, click here.
CRB is a leading provider of sustainable engineering, architecture, construction and consulting solutions to the global life sciences and food and beverage industries. Our more than 1,400 employees provide best-in-class solutions that drive success and positive change for our clients, our people and our communities. CRB is a privately held company with a rich history of serving clients throughout the world, consistently striving for the highest standard of technical knowledge, creativity and execution.
More from CRB